Literature DB >> 24169044

Spice/K2 drugs--more than innocent substitutes for marijuana.

Jolanta B Zawilska1, Jakub Wojcieszak1.   

Abstract

Smokeable herbal mixtures containing synthetic agonists of cannabinoid receptors, known under brand names such as Spice, K2 and Kronic, represent a relatively new type of designer psychoactive drugs that has recently emerged on the recreational drug market. Although the Spice packages are labelled 'not for human consumption' or 'for aromatherapy only' and declared to be purely herbal, these herbal mixtures produce cannabis-like effects after smoking. This review surveys the current state of knowledge regarding the pharmacological properties of synthetic cannabimimetics and the prevalence and pattern of their use. Special emphasis is given to the negative consequences of using these products, including, among others, hallucinations, psychoses with delusions, seizures, cardiovascular symptoms and acute kidney injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24169044     DOI: 10.1017/S1461145713001247

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  24 in total

1.  Emerging and Underrecognized Complications of Illicit Drug Use.

Authors:  Alysse G Wurcel; Elisabeth A Merchant; Roger P Clark; David R Stone
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

2.  Positive Allosteric Modulation of the 5-HT1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans.

Authors:  Hideaki Yano; Pramisha Adhikari; Sett Naing; Alexander F Hoffman; Michael H Baumann; Carl R Lupica; Lei Shi
Journal:  ACS Chem Neurosci       Date:  2020-04-30       Impact factor: 4.418

Review 3.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 4.  Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.

Authors:  Eun Yong Chung; Hye Jin Cha; Hyun Kyu Min; Jaesuk Yun
Journal:  Arch Pharm Res       Date:  2021-04-02       Impact factor: 4.946

Review 5.  Synthetic Pot: Not Your Grandfather's Marijuana.

Authors:  Benjamin M Ford; Sherrica Tai; William E Fantegrossi; Paul L Prather
Journal:  Trends Pharmacol Sci       Date:  2017-02-02       Impact factor: 14.819

6.  Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication.

Authors:  Ahmet Kırgız; Havva Kaldırım
Journal:  Int Ophthalmol       Date:  2017-12-23       Impact factor: 2.031

7.  Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory.

Authors:  Erin K Kirschmann; Michael W Pollock; Vidhya Nagarajan; Mary M Torregrossa
Journal:  Neuropsychopharmacology       Date:  2016-09-01       Impact factor: 7.853

8.  Stroke due to Bonzai use: two patients.

Authors:  Baki Dogan; Hakan Dogru; Levent Gungor; Kemal Balci
Journal:  World J Emerg Med       Date:  2016

9.  A 15-year-old boy with acute onset abdominal pain and hypertension.

Authors:  Rosheen Mary Grady; Vladimir Belostotsky; Kristen M Hallett; Christina N Grant
Journal:  Paediatr Child Health       Date:  2017-06-14       Impact factor: 2.253

10.  Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.

Authors:  Vera L Alves; João L Gonçalves; Joselin Aguiar; Maria J Caldeira; Helena M Teixeira; José S Câmara
Journal:  Anal Bioanal Chem       Date:  2021-02-11       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.